Aeterna Zentaris Company Profile (NASDAQ:AEZS)

Analyst Ratings

Consensus Ratings for Aeterna Zentaris (NASDAQ:AEZS) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (210.08% upside)

Analysts' Ratings History for Aeterna Zentaris (NASDAQ:AEZS)
Show:
DateFirmActionRatingPrice TargetActions
7/10/2016HC WainwrightReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/5/2016Maxim GroupReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2016Canaccord GenuityReiterated RatingBuy$13.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Aeterna Zentaris (NASDAQ:AEZS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
3/29/2016Q415($1.30)($1.46)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.06)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q215($0.08)($0.14)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015($0.10)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/17/2015Q414($0.16)$0.06ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014($0.16)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014($0.30)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/20/2014Q413($0.04)($0.22)$12.41 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/21/2013Q412($0.31)($0.29)$7.96 million$9.16 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2012Q312($0.43)($0.35)$8.38 million$7.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aeterna Zentaris (NASDAQ:AEZS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Aeterna Zentaris (NASDAQ:AEZS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aeterna Zentaris (NASDAQ:AEZS)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Aeterna Zentaris (NASDAQ:AEZS)
DateHeadline
07/23/16 02:19 PMAre Analysts Bearish AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) After Last Week? - Press Telegraph
07/22/16 07:21 PMHow Analysts Feel About AEterna Zentaris Inc. (USA) After Today's ... - Consumer Eagle
07/22/16 07:21 PMAEterna Zentaris Inc. (USA)'s Trend Down, Especially After Today's Weak Session - Consumer Eagle
07/22/16 10:30 AMCould AEterna Zentaris Inc. (USA) Rise Even More? The Stock Had Another Big Increase Today - Consumer Eagle
07/21/16 02:20 PMEarnings Focus and Crowd Sourced Sentiment Review for AEterna Zentaris Inc. (NASDAQ:AEZS) - TGP
07/21/16 02:20 PMIs $12 Price Target Attainable For AEterna Zentaris Inc. (NASDAQ:AEZS)? - Investor Newswire
07/20/16 10:28 AMAEterna Zentaris Inc. (USA) Can't Be More Risky. Trades Sigfnicicantly Lower - Consumer Eagle
07/20/16 10:28 AMAEterna Zentaris Inc. (NASDAQ:AEZS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/18/16 02:21 PMTrading Performance and Target Watch for AEterna Zentaris Inc. (NASDAQ:AEZS) - Press Telegraph
07/17/16 07:05 AMAeterna Zentaris Incorporated (NASDAQ:AEZS) Shorted Shares Decreased By 1.49% - Consumer Eagle
07/15/16 12:55 PMHow Many AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)'s Analysts Are Bullish? - Consumer Eagle
07/13/16 07:53 PMStrong Sell Calls For AEterna Zentaris Inc. (NASDAQ:AEZS) At 0 - Investor Newswire
07/13/16 10:24 AMAeterna Zentaris Incorporated (NASDAQ:AEZS) Sellers Covered 1.49% of Their Shorts - Consumer Eagle
07/12/16 02:22 PMHC Wainwright Analyst Pounds the Table on AEterna Zentaris Inc. (USA) - Smarter Analyst
07/12/16 02:22 PMAEterna Zentaris Inc. (NASDAQ:AEZS) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/10/16 07:07 AMNext Weeks Broker Price Targets For AEterna Zentaris Inc. (AEZS) - Fiscal Standard
07/09/16 10:26 AMAeterna Zentaris Incorporated (NASDAQ:AEZS) Short Interest Decreased By 1.49% - Press Telegraph
07/08/16 10:23 AMHot Alert: Aeterna Zentaris Inc. (NASDAQ:AEZS), Kinder Morgan, Inc. (NYSE:KMI), Unifi Inc. (NYSE:UFI), Gorman-Rupp ... - KC Register
07/07/16 02:20 PMNew Broker Ratings For AEterna Zentaris Inc. (AEZS) - FTSE News
07/06/16 08:03 PMAEterna Zentaris Inc. (NASDAQ:AEZS) Expected to Reach Highs Of $12 - Investor Newswire
07/05/16 02:19 PMAnalysts Shine Light On AEterna Zentaris Inc. (USA) (AEZS) And OraSure Technologies, Inc. (OSUR) Following Recent ... - Smarter Analyst
07/05/16 07:07 AMInvestors Are Watching: Aeterna Zentaris Inc. (NASDAQ:AEZS), Pacific Coast Oil Trust (NYSE:ROYT), Aaron's, Inc ... - KC Register
07/04/16 02:20 PMRecommendation Trends Analysis: Aeterna Zentaris Inc. (NASDAQ:AEZS) - News Oracle
07/04/16 07:07 AMGaps Up in Stock Trading – PLSE, DFBG, QBAK, TOF, XPLR, ACLS, PTIE
07/04/16 07:07 AMBIND Gallups On Stalking Horse Offer, KBIO Is Back, ALNY Abuzz
07/02/16 10:02 AMAeterna Zentaris (AEZS), Orient EuroPharma Enter License Agreement for Zoptrex in Taiwan and Southeast Asia
07/01/16 10:18 AMMid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs
07/01/16 10:18 AMCompany Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) and Orient EuroPharma Sign Exclusive License ... - Smarter Analyst
07/01/16 08:52 AMAeterna Zentaris inks Zoptrex license deal in Asia; shares ahead 10% premarket -
07/01/16 07:51 AM07.01.2016 Aeterna Zentaris and Orient EuroPharma Co., Ltd. Sign Exclusive License Agreement for Zoptrex™ in Taiwan and Southeast Asia - [at noodls] - CHARLESTON, S.C.--(BUSINESS WIRE)--Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the 'Company') and Orient EuroPharma Co., Ltd. ('OEP') today announced the signing of an exclusive license agreement ...
07/01/16 07:32 AM8:32 am Aeterna Zentaris signs an exclusive license agreement with Cyntec for Zoptrex, indicated for the treatment of endometrial cancer -
07/01/16 07:30 AMAeterna Zentaris and Orient EuroPharma Co., Ltd. Sign Exclusive License Agreement for Zoptrex™ in Taiwan and Southeast Asia - [Business Wire] - CHARLESTON, S.C.--(BUSINESSWIRE)-- Aeterna Zentaris Inc. (NASDAQ:AEZS - News) (TSX:AEZ.TO - News) (the “Company”) and Orient EuroPharma Co., Ltd. (“OEP”) today announced the signing of an exclusive license agreement between the Company and Cyntec Co., Ltd., an affiliate of OEP (“Cyntec”), for the Company’s lead anti-cancer compound, Zoptrex™ (zoptarelin doxorubicin), for the initial indication of endometrial cancer, for Taiwan and nine countries in Southeast Asia (the “Territory”). Zoptrex™, a novel synthetic peptide carrier linked to doxorubicin as a New Chemical Entity (NCE), is currently in a fully-enrolled Phase 3 clinical trial in endometrial cancer.
06/29/16 07:30 PMAeterna Zentaris Incorporated (NASDAQ:AEZS) Sellers Covered 1.49% of Their Shorts - Engelwood Daily
06/29/16 02:20 PMBrokers Issue Average Price Target Of 6.71 On AEterna Zentaris Inc. (AEZS) - Fiscal Standard
06/28/16 02:35 PMAEterna Zentaris Inc. (NASDAQ:AEZS) Earnings Glance and Target Price Review - Engelwood Daily
06/25/16 02:21 PMWill AEterna Zentaris Inc. (USA) Short Squeeze Soon? The Stock Just Gapped Down - Press Telegraph
06/24/16 10:17 AMAre Analysts Bearish AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) After Last Week? - Engelwood Daily
06/23/16 10:04 AMStrong Buy Calls Count For AEterna Zentaris Inc. (NASDAQ:AEZS) At 3 - Investor Newswire
06/21/16 07:06 AMAEterna Zentaris Inc. (AEZS) Current Analyst Ratings - Fiscal Standard
06/20/16 02:19 PMAEterna Zentaris Inc. (AEZS) Analyst Price Targets For The Coming Week - Fiscal Standard
06/16/16 09:49 AM05.23.2016 Aeterna Zentaris Elects Ms. Carolyn Egbert as Independent Chair of the Board - [at noodls] - CHARLESTON, S.C.--(BUSINESS WIRE)--Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the 'Company'), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, ...
06/16/16 09:39 AM06.14.2016 Aeterna Zentaris Announces IND Submission by Sinopharm A-Think - [at noodls] - CHARLESTON, S.C.--(BUSINESS WIRE)--Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the 'Company') today announced that its licensee, Sinopharm A-Think Pharmaceuticals Co., Ltd. ('Sinopharm A-Think'), ...
06/16/16 09:39 AM06.06.2016 Aeterna Zentaris Reconfirms Commitment to LHRH-receptor Targeting Zoptrex™ During 2016 ASCO Annual Meeting - [at noodls] - CHARLESTON, S.C.--(BUSINESS WIRE)--Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the 'Company') today reconfirmed its commitment to LHRH-receptor targeted therapy and its expectation that the pivotal, ...
06/15/16 07:24 PMTrend Of Rating Given To AEterna Zentaris Inc. (NASDAQ:AEZS) - Investor Newswire
06/15/16 02:21 PMMaxim Reiterates Buy on AEterna Zentaris Inc. (USA) (AEZS) Following IND Submission for Zoptrex in China - Smarter Analyst
06/14/16 04:00 PMAeterna Zentaris Announces IND Submission by Sinopharm A-Think - [Business Wire] - Aeterna Zentaris Inc. today announced that its licensee, Sinopharm A-Think Pharmaceuticals Co., Ltd. , which is affiliated with the largest state-owned pharmaceutical company in the People’s Republic of China, today submitted an Investigational New Drug application for Zoptrex™ to the Chinese State Food and Drug Administration , remaining on track to commence its clinical program during the first half ...
06/07/16 10:43 AMPremarket Runners: Biogen Inc. (NASDAQ:BIIB), AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) - iStreetWire
06/07/16 10:43 AMSarepta Therapeutics Inc, AEterna Zentaris Inc, Zillow Group Inc, ProNAi Therapeutics Inc Among Top Pre-Market ... - TCC
06/06/16 07:57 PMCompany Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Reconfirms Commitment to LHRH-receptor Targeting ... - Smarter Analyst
06/06/16 04:33 PMBRIEF-Aeterna zentaris to file a NDA for zoptrex in first half of 2017 - * Aeterna Zentaris reconfirms commitment to LHRH-receptor targeting zoptrex during 2016 ASCO annual meeting

Social

About Aeterna Zentaris

Aeterna Zentaris logoAeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company engaged in developing treatments in oncology, endocrinology and women's health. The Company has three wholly owned direct and indirect subsidiaries: AEZS GmbH, based in Frankfurt, Germany, Zentaris IVF GmbH, a direct wholly owned subsidiary of AEZS Germany based in Frankfurt, Germany, and Aeterna Zentaris, Inc. Its drug development efforts are focused on two compounds, zoptarelin doxorubicin and Macrilen, which are in clinical development, and on two oncology compounds (an Erk inhibitor and Luteinizing Hormone-Releasing Hormone-disorazol Z product candidates), which are in pre-clinical development. Zoptarelin doxorubicin represents a hybrid molecule composed of a synthetic peptide carrier and a chemotherapy agent, doxorubicin. Macrilen (macimorelin acetate) is an orally available peptidomimetic ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the ghrelin receptor.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AEZS
  • CUSIP:
Key Metrics:
  • Previous Close: $3.51
  • 50 Day Moving Average: $3.45
  • 200 Day Moving Average: $3.45
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $34.19M
  • Beta: 1.76
  • Current Year EPS Consensus Estimate: $-3.91 EPS
  • Next Year EPS Consensus Estimate: $-2.1 EPS
Additional Links:
Aeterna Zentaris (NASDAQ:AEZS) Chart for Saturday, July, 23, 2016